Compare

Compare archived captures

This view highlights text differences between two archived captures. It does not interpret meaning or provide guidance.

Descriptive changes only

This comparison highlights text changes between archived captures. It does not interpret the change or provide medical advice. For up-to-date recommendations, always consult the official source website.

Need to cite this comparison? See /cite.

Compare to the live page View snapshot

Earlier capture

Drug Quality Surveillance Program - Canada.ca

Apr 19, 2025

legacy-hc-2025-04-21

ID 253761

Original URL ↗

View snapshot

Later capture

Drug Quality Surveillance Program - Canada.ca

Jan 2, 2026

hc-20260101

ID 428877

Original URL ↗

View snapshot

updated1 sections changed

1 sections changed0 added0 removed+0 / -1 linesChange ratio: 1%

---

+++

@@ -42,5 +42,4 @@

Drug identification number (DIN)

Active pharmaceutical ingredients - Good manufacturing practices - Questions and answers

Page details

-Date modified:

2024-02-05